- Home
- HOWL vs QSI Comparison
HOWL vs QSI Comparison
Compare HOWL & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- QSI
- Stock Information
- Founded
- HOWL 2017
- QSI 2013
- Country
- HOWL United States
- QSI United States
- Employees
- HOWL N/A
- QSI N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- HOWL Health Care
- QSI Health Care
- Exchange
- HOWL Nasdaq
- QSI Nasdaq
- Market Cap
- HOWL 87.4M
- QSI 94.1M
- IPO Year
- HOWL 2021
- QSI N/A
- Fundamental
- Price
- HOWL $1.79
- QSI $1.21
- Analyst Decision
- HOWL Strong Buy
- QSI Buy
- Analyst Count
- HOWL 2
- QSI 2
- Target Price
- HOWL $13.50
- QSI $2.50
- AVG Volume (30 Days)
- HOWL 656.6K
- QSI 15.7M
- Earning Date
- HOWL 11-07-2024
- QSI 11-12-2024
- Dividend Yield
- HOWL N/A
- QSI N/A
- EPS Growth
- HOWL N/A
- QSI N/A
- EPS
- HOWL N/A
- QSI N/A
- Revenue
- HOWL $3,386,000.00
- QSI $2,266,000.00
- Revenue This Year
- HOWL N/A
- QSI $270.89
- Revenue Next Year
- HOWL $191.98
- QSI $214.75
- P/E Ratio
- HOWL N/A
- QSI N/A
- Revenue Growth
- HOWL N/A
- QSI 232.26
- 52 Week Low
- HOWL $1.58
- QSI $0.61
- 52 Week High
- HOWL $8.19
- QSI $2.43
- Technical
- Relative Strength Index (RSI)
- HOWL 32.55
- QSI 63.06
- Support Level
- HOWL $1.58
- QSI $0.61
- Resistance Level
- HOWL $2.24
- QSI $1.89
- Average True Range (ATR)
- HOWL 0.16
- QSI 0.13
- MACD
- HOWL -0.09
- QSI 0.04
- Stochastic Oscillator
- HOWL 7.01
- QSI 46.79
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.